Pulmonx Corp
LUNGNasdaqCIK 1127537HealthcareFiscal year ends Dec 31
Reports and events: 76 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2716:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001127537-26-000042 |
| 2026-08-0416:46 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001127537-26-000039 |
| 2026-07-2916:07 ET | 8-K | 2.02 Results of operations | 0001127537-26-000035 |
| 2026-06-0416:04 ET | 8-K | 5.07 Shareholder vote results | 0001127537-26-000031 |
| 2026-05-0416:32 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001127537-26-000025 |
| 2026-04-2916:13 ET | 8-K | 2.02 Results of operations | 0001127537-26-000020 |
| 2026-04-2216:07 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001140361-26-016105 |
| 2026-03-1017:03 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001127537-26-000015 |
| 2026-03-0519:10 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-092064 |
| 2026-03-0416:11 ET | 8-K | 2.02 Results of operations | 0001127537-26-000003 |
| 2025-11-1216:25 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001127537-25-000059 |
| 2025-11-1216:05 ET | 8-K | 2.02 Results of operations | 0001127537-25-000058 |
| 2025-10-2716:05 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001127537-25-000052 |
| 2025-08-0117:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001127537-25-000045 |
| 2025-07-3016:06 ET | 8-K | 2.02 Results of operations | 0001127537-25-000041 |
| 2025-05-2317:55 ET | 8-K | 5.07 Shareholder vote results | 0001127537-25-000028 |
| 2025-05-0216:18 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001127537-25-000026 |
| 2025-04-3016:10 ET | 8-K | 2.02 Results of operations | 0001127537-25-000023 |
| 2025-04-0816:01 ET | DEF 14A | Proxy statementPeriod 2025-05-22 | 0001140361-25-012814 |
| 2025-02-2516:27 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001127537-25-000012 |
| 2025-02-1916:09 ET | 8-K | 2.02 Results of operations | 0001127537-25-000003 |
| 2024-11-0116:23 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001127537-24-000087 |
| 2024-10-3016:10 ET | 8-K | 2.02 Results of operations | 0001127537-24-000082 |
| 2024-08-0216:27 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001127537-24-000077 |
| 2024-07-3116:10 ET | 8-K | 2.02 Results of operations | 0001127537-24-000073 |
| 2024-05-2316:24 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001127537-24-000063 |
| 2024-05-1716:03 ET | 8-K | 5.07 Shareholder vote results | 0001127537-24-000057 |
| 2024-05-0316:13 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001127537-24-000052 |
| 2024-05-0116:10 ET | 8-K | 2.02 Results of operations | 0001127537-24-000045 |
| 2024-04-0516:08 ET | DEF 14A | Proxy statementPeriod 2024-05-16 | 0001140361-24-018313 |
| 2024-04-0216:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001127537-24-000039 |
| 2024-02-2716:07 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001127537-24-000024 |
| 2024-02-2116:08 ET | 8-K | 2.02 Results of operations | 0001127537-24-000013 |
| 2024-02-2116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001127537-24-000012 |
| 2023-11-0316:04 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001127537-23-000048 |
| 2023-10-3016:06 ET | 8-K | 2.02 Results of operations | 0001127537-23-000042 |
| 2023-10-1016:06 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-253468 |
| 2023-08-0416:21 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001127537-23-000036 |
| 2023-08-0216:06 ET | 8-K | 2.02 Results of operations | 0001127537-23-000032 |
| 2023-05-1816:09 ET | 8-K | 5.07 Shareholder vote results | 0001127537-23-000023 |
| 2023-05-0817:12 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001127537-23-000018 |
| 2023-05-0216:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001127537-23-000014 |
| 2023-04-0416:40 ET | DEF 14A | Proxy statementPeriod 2023-05-17 | 0001193125-23-090955 |
| 2023-03-0116:08 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001127537-23-000011 |
| 2023-02-2216:06 ET | 8-K | 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001127537-23-000005 |
| 2022-11-0816:26 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001127537-22-000053 |
| 2022-11-0316:03 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations | 0001127537-22-000048 |
| 2022-08-0816:28 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001127537-22-000037 |
| 2022-08-0216:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001127537-22-000033 |
| 2022-05-2716:31 ET | 8-K | 5.07 Shareholder vote results | 0001127537-22-000029 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:08 ET. Listed shows no prices and gives no investment advice.